Quick Answer
ASCENTAGE PHARMA GROUP INTERNATIONAL reported Gross Profit of $951.57 million for fiscal year 2024.
ASCENTAGE PHARMA GROUP INTERNATIONAL Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $951.57M | +397.1% |
| 2023 | $191.44M | +2.0% |
| 2022 | $187.71M | — |
- ASCENTAGE PHARMA GROUP INTERNATIONAL showed an increase of +397.1% in Gross Profit compared to the prior fiscal year.
- Over the 2022–2024 period, ASCENTAGE PHARMA GROUP INTERNATIONAL’s gross profit has grown by 406.9% (from $187.71 million to $951.57 million).
- The most recent figure is from ASCENTAGE PHARMA GROUP INTERNATIONAL’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 16, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: